欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2325/001
药品名称Zerlinda
活性成分
    • zoledronic acid monohydrate 0.04 mg/ml
剂型Solution for infusion
上市许可持有人Actavis Group PTC ehf. Address: Reykjavíkurvegi 76-78, 220 Hafnarfjördur, Island
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Ireland (IE)
    • Norway (NO)
      Zerlinda
    • Poland (PL)
    • Romania (RO)
      ZERLINDA 4 mg/100 ml solutie perfuzabila
许可日期2013/10/03
最近更新日期2023/09/01
药物ATC编码
    • M05BA08 zoledronic acid
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase